Sonoma Pharmaceuticals (SNOA) Return on Capital Employed Growth (1y) (2012 - 2026)
Sonoma Pharmaceuticals (SNOA) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 333.00 |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -469.00 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 8.00 |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 220.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 802.00 |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 340.00 |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 573.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.12 Mn | -222,819.83 | 2.58 Mn | 2,579.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,579.00 |
| Mar 31, 2026 | 1,124.00 |
| Dec 31, 2025 | 1,570.00 |
| Sep 30, 2025 | 974.00 |
| Jun 30, 2025 | 525.00 |
| Mar 31, 2025 | 418.00 |
| Dec 31, 2024 | -459.00 |
| Sep 30, 2024 | 587.00 |
| Jun 30, 2024 | -313.00 |
| Mar 31, 2024 | -270.00 |
| Dec 31, 2023 | 2,149.00 |
| Sep 30, 2023 | -239.00 |
| Jun 30, 2023 | 320.00 |
| Mar 31, 2023 | 414.00 |
| Dec 31, 2022 | -2,575.00 |
| Sep 30, 2022 | -734.00 |
| Jun 30, 2022 | -484.00 |
| Mar 31, 2022 | -1,682.00 |
| Dec 31, 2021 | -893.00 |
| Sep 30, 2021 | -173.00 |